Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England

    Research output: Contribution to journalLetterpeer-review

    7 Citations (Scopus)

    Abstract

    Highlights
    • Patients with severe COVID-19 disease are at risk of fungal co/secondary infections.
    • COVID-associated pulmonary aspergillosis and candidemia are most common.
    • We estimate impact of fungal infections on outcome in COVID ICU patients in England.
    • Aspergillosis and candidemia independently increase COVID-19-associated mortality.
    • Length-of-stay was extended in COVID-19 patients with either fungal infection.
    Original languageEnglish
    Pages (from-to)579-613
    Number of pages35
    JournalJournal of Infection
    Volume84
    Issue number4
    Early online date4 Jan 2022
    DOIs
    Publication statusPublished - 8 Apr 2022

    Keywords

    • CAPA
    • COVID-19
    • Fungal secondary infection
    • HDU
    • ICU
    • Length of stay
    • Mortality

    Fingerprint

    Dive into the research topics of 'Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England'. Together they form a unique fingerprint.

    Cite this